Keep the evidence in view

Every claim needs context.

A medicine label, a clinical study and a provider page have different jobs. Open a record to see where we used it.

CoreAge Rx: Non-Hormonal ParoxetineChecked 2026-09-27

Provider product page

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

National Institute on Aging: Sleep Problems and MenopauseChecked 2026-09-27

Government patient guidance

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

DailyMed: Brisdelle prescribing information, revised April 2025Checked 2026-09-27

FDA-approved labeling

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

FDA: Understanding Unapproved Use of Approved DrugsChecked 2026-09-27

FDA guidance

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Midi: Hot Flashes and Night Sweats TreatmentChecked 2026-09-27

Provider service page

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Midi: Pricing and InsuranceChecked 2026-09-27

Provider pricing and access terms

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Midi: Hormone Replacement Therapy and Access TermsChecked 2026-09-27

Provider access terms

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Evernow: Sleep CareChecked 2026-09-27

Provider service page

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Evernow: ParoxetineChecked 2026-09-27

Provider treatment page

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Evernow: Frequently Asked QuestionsChecked 2026-09-27

Provider service and pricing terms

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

DailyMed: Veozah prescribing information, updated February 2026Checked 2026-09-27

FDA-approved labeling

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Bayer: Lynkuet prescribing information, revised August 2026Checked 2026-09-27

Current manufacturer prescribing information

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

The Menopause Society: 2023 Nonhormone Therapy Position StatementChecked 2026-09-27

Professional society evidence review

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Evernow: VeozahChecked 2026-09-27

Provider treatment page

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Evernow: Night SweatsChecked 2026-09-27

Provider symptom education

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

FDA: Lynkuet original-approval drug trials snapshotChecked 2026-09-27

Regulatory trial evidence summary

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

National Institute on Aging: Hot flashes, what can I do?Checked 2026-09-27

NIH patient information

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

NHLBI: Insomnia diagnosis and sleep historyChecked 2026-09-27

NIH patient information

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

NHLBI: Sleep apnea symptomsChecked 2026-09-27

NIH patient information

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Pinkerton et al.: OASIS 1 and 2 randomized clinical trials, JAMA 2024Checked 2026-09-27

Primary randomized trial abstract

Checked 2026-09-27. Source content and service terms may change.

Open original source ↗

Read it in context

Alloy: ParoxetineChecked 2026-09-29

Official 10 mg offer; FDA-approved wording is not independently applied to the advertised preparation, and one-month/three-month supply wording remains unresolved

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

DailyMed: Brisdelle paroxetine capsulesChecked 2026-09-29

Exact oral 7.5 mg capsule label updated April 28, 2025; approved vasomotor indication and warnings remain product-specific, not Alloy 10 mg authentication

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Alloy: terms of useChecked 2026-09-28

Dated platform terms; subscription and shipment cancellation deadlines, first-shipment refund conditions and service-fee exclusions kept separate

Checked 2026-09-28. Source content and service terms may change.

Open original source ↗

Read it in context

NHLBI: InsomniaChecked 2026-09-29

Federal sleep-disorder overview, last updated March 24, 2022; diagnostic context, not attribution of a reader’s waking to menopause or a clinic assessment

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Gennev: Symptoms and TreatmentChecked 2026-09-29

Official clinical service and treatment categories; exact nonhormonal medicine selection unconfirmed

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

The Menopause Society: 2023 nonhormone therapy position statementChecked 2026-09-29

PubMed primary professional abstract; vasomotor-symptom evidence categories, dated 2023 and not provider-specific efficacy or later-drug approval

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Gennev: insurance and pricingChecked 2026-09-28

Dated provider fee table and coverage process; doctor/dietitian initial/follow-up costs are separate from pharmacy charges

Checked 2026-09-28. Source content and service terms may change.

Open original source ↗

Read it in context

NIA: Sleep and Older AdultsChecked 2026-09-29

Federal older-adult sleep information, reviewed February 6, 2025; multiple causes and daily-function context, not a personal diagnosis or a treatment schedule

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

MyMenopauseRx: TreatmentsChecked 2026-09-29

Official clinical offer names fezolinetant and other treatment categories; no personal prescription or outcome confirmed

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

DailyMed: Veozah fezolinetant tabletsChecked 2026-09-29

Exact label revised February 2026 with boxed hepatotoxicity warning, required clinical monitoring and product-specific contraindications; not personal clearance

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

MyMenopauseRx: telehealth FAQChecked 2026-09-28

Dated provider visit/pharmacy/refill/coverage/cancellation record; personal prescription, generic identity and clinical decisions remain unverified

Checked 2026-09-28. Source content and service terms may change.

Open original source ↗

Read it in context

Pandia Health: Menopause careChecked 2026-09-29

Official current clinical/pharmacy menu includes paroxetine and Veozah; pharmacy stock, selected medicine and malformed three-month billed amount unresolved

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Stella US: Menopause careChecked 2026-09-29

US clinical offer, age/access and payment information; nonhormonal category and coaching do not identify a particular medicine

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Wisp: Menopause Consult OnlineChecked 2026-09-29

Official clinical offer and separately billed local-pharmacy medicines; exact systemic nonhormonal medicine offer unconfirmed

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Wisp: Non-Hormonal Vaginal MoisturizerChecked 2026-09-29

Official specific local-dryness offer and latex-condom caution; marketing does not establish vasomotor efficacy or a complete formulation

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Wisp: terms of useChecked 2026-09-28

Dated platform transaction terms; prescription renewal review, 48-hour cancellation and discretionary product remedies; not individual legal advice

Checked 2026-09-28. Source content and service terms may change.

Open original source ↗

Read it in context

Joi + Blokes: Clinical care overviewChecked 2026-09-29

Official menopause clinical service and coaching roles; no specific nonhormonal vasomotor prescription confirmed

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Joi + Blokes: Hormone replacement therapyChecked 2026-09-29

Hormonal program prices and quarterly commitments; not a confirmed nonhormonal medicine menu or quote

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

DailyMed: Lynkuet elinzanetant capsulesChecked 2026-09-29

Exact current label revised August 2026; product-specific warnings and use, not a claim any reviewed clinic supplies it

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

FOLX: Perimenopause and menopause supportChecked 2026-09-29

Official LGBTQIA+ clinical service description with nonhormonal medication category; specific product and indication unconfirmed

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

FDA: Understanding unapproved use of approved drugsChecked 2026-09-29

Federal explanation distinguishing an approved medicine from an unapproved use; not a personal recommendation

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

FOLX: What can a clinician help with?Checked 2026-09-29

Official clinical service, published visit charges and appointment cancellation terms; not personal availability

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

FOLX: What is a membership?Checked 2026-09-29

Official membership explainer dated August 2023 as currently accessible; monthly versus annual billed amounts, services extra

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

FOLX: Membership cancellation policyChecked 2026-09-29

Official membership notice, annual account control timing, no membership refunds and remaining bills; separate appointment cancellation terms

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Maven: Hormone Care EssentialsChecked 2026-09-29

Direct clinical offer with stated nonhormonal medicine families and one-time care package; individual eligibility, selected drug and refund outcome unconfirmed

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Maven: Terms of UseChecked 2026-09-29

Official platform terms updated September 23, 2026; independent practitioner roles and enterprise distinctions, not a complete selected Hormone Care refund agreement

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Veozah (fezolinetant) US prescribing informationChecked 2026-09-29

Exact official DailyMed label. Revised February 2026; boxed hepatotoxicity warning; same-day official HTML record reviewed with original timestamp

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Lynkuet (elinzanetant) US prescribing informationChecked 2026-09-29

Exact official DailyMed label. Text revised August 2026; page metadata says updated June 16, 2026; same-day official HTML record reviewed with original timestamp

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Brisdelle (paroxetine) US prescribing informationChecked 2026-09-29

Exact official DailyMed label. Revised April 2025; exact 7.5 mg capsule, not general paroxetine tablets; same-day official HTML record reviewed with original timestamp

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Allara: care program and service FAQsChecked 2026-09-29

Actual menopause care scope; state and program distinctions

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Allara help center: program costsChecked 2026-09-29

Official linked support record; self-pay, insurance and excluded charges

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Allara: how care worksChecked 2026-09-29

Broader weight-care page with different Complete Care and nutrition prices; selected quote unresolved

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Allara: terms and conditionsChecked 2026-09-29

Subscription cancellation and discretionary refund conditions; no legal advice

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Hello Alpha: menopause treatmentChecked 2026-09-29

Clinical service page; local estrogen and systemic nonhormonal categories need separation

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Hello Alpha: membershipChecked 2026-09-29

Published monthly plan and visit units; separate prescription charges

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Hello Alpha: terms of useChecked 2026-09-29

Commercial terms; automatic renewal, separate refill cancellation and refund limits

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Myla Health: consultation servicesChecked 2026-09-29

UK private clinical service; NHS prescribing remains separate

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Myla Health: prices effective April 1, 2026Checked 2026-09-29

UK visit and prescription-administration fees, excluding actual medicine

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Myla Health: patient FAQsChecked 2026-09-29

UK location, billing, cancellation and investigation responsibility conditions

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Newson Clinic: consultationsChecked 2026-09-29

UK hormone and nonhormonal consultation scope; exact drug unconfirmed

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Newson Clinic: current services and displayed feesChecked 2026-09-29

Commercial service and fee record; no independent efficacy claim

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Mass General Brigham: Menopause and Midlife ClinicChecked 2026-09-29

Regional clinical program and appointment contacts; no exact drug menu verified

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Penn Medicine: menopause and postmenopause careChecked 2026-09-29

Clinical service; current new center focus on cancer survivors and previvors

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Penn Medicine: contact and schedulingChecked 2026-09-29

Appointment contact hours; no personal availability or price established

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

FDA: unapproved uses of approved drugsChecked 2026-09-29

Regulator explanation; product and indication scope

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

NIA: sleep problems and menopauseChecked 2026-09-29

Patient guidance, content reviewed September 30, 2021; multiple contributors and distinct insomnia assessment

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Paroxetine 7.5 mg: pooled phase 3 sleep analysisChecked 2026-09-29

Primary trial analysis, predefined secondary self-reported endpoints; placebo comparison and Noven funding; historical regulatory/discontinuation statements not current guidance

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Fezolinetant: DAYLIGHT phase 3b randomized trialChecked 2026-09-29

Primary placebo-controlled 24-week study; secondary sleep P values not multiplicity controlled; Astellas funding; current label controls safety

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Elinzanetant: OASIS 1 and 2 randomized trialsChecked 2026-09-29

Primary placebo-controlled trials; sleep T-score secondary endpoint at week 12, crossover thereafter; current label controls later safety warnings

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

JAMA: OASIS 1 and 2 sponsor and funder roleChecked 2026-09-29

Original primary publisher disclosure; Bayer sponsorship and study, analysis, manuscript and submission roles

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Duke Health — MenopauseChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost. Page states internal medical review December 7, 2021; access date is separate.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Cleveland Clinic — Menopause TreatmentChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Mayo Clinic — Menopause and Women’s Sexual Health ClinicChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost. Rochester, Minnesota service; page dated February 3, 2026.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Johns Hopkins Medicine — Menopause ClinicChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Mount Sinai — MenopauseChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost. Historical SWAN study-year wording is not adopted as a current timeline or medicine trial.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Northwestern Medicine — Program for MenopauseChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

UCLA Health — Comprehensive Menopause Program Clinical ServicesChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Stanford Health Care — Menopause TreatmentsChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

University of Utah Health — Midlife Women’s Health and Menopause ProgramChecked 2026-09-29

Official menopause clinical service description. Treatment categories and symptom scope do not establish a selected medicine, individual sleep diagnosis, personal outcome or total cost.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

UCLA Health — Comprehensive Menopause Program Patient InformationChecked 2026-09-29

Official UCLA appointment instructions: questionnaire preparation, as-needed follow-up and annual health assessment. The annual review is not a drug-specific monitoring interval.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

University of Utah Health — What to Expect at Your Midlife AppointmentChecked 2026-09-29

Official Utah appointment guide, internally reviewed February 2025: preparation and 40–60-minute first visit. Symptom ranking is not a diagnosis, eligibility score or medicine protocol.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

National Institute on Aging — Sleep Problems and Menopause: What Can I Do?Checked 2026-09-29

Federal patient explanation, internally reviewed September 30, 2021. Multiple contributors to poor sleep, uncertain waking/hot-flash sequence and trained-professional insomnia therapy; no personal diagnostic or bedtime regimen.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

Pinkerton and colleagues — Low-dose paroxetine improves sleep in women with vasomotor symptoms associated with menopauseChecked 2026-09-29

Primary 2015 report of predefined secondary sleep outcomes in two placebo-controlled trials of a specific paroxetine mesylate capsule. Self-reported outcomes; sleep-onset and other scales did not show uniform benefit. Industry funded; not an insomnia indication, current safety clearance or clinic outcome.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

NIH Discover Women’s Health — InsomniaChecked 2026-09-29

Federal research overview of insomnia symptoms, assessment and treatment. Used for distinctions between sleep concerns; does not confirm a provider service or a particular medicine’s insomnia approval.

Checked 2026-09-29. Source content and service terms may change.

Open original source ↗

Read it in context

DailyMed — BRISDELLE paroxetine capsule, Legacy Pharma USA, Inc.Checked 2026-10-21

Exact capsule prescribing information revised April 2025. Menopausal vasomotor indication and current safety information remain separate from older secondary sleep outcomes and from a clinic formulary.

Checked 2026-10-21. Source content and service terms may change.

Open original source ↗

Read it in context

DailyMed — VEOZAH fezolinetant tablet, Astellas Pharma US, Inc.Checked 2026-10-21

Complete current prescribing information revised February 2026, including boxed hepatotoxicity warning, all three contraindications, liver-assessment duties and patient warning response. Vasomotor indication is not an insomnia indication; no personal laboratory calendar or eligibility decision.

Checked 2026-10-21. Source content and service terms may change.

Open original source ↗

Read it in context

CoreAge Rx: shipping reference and service detailsChecked 2026-10-12

Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test

Checked 2026-10-12. Source content and service terms may change.

Open original source ↗

Read it in context

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.Checked 2026-10-21

Indexed primary study abstract

Checked 2026-10-21. Source content and service terms may change.

Open original source ↗

Read it in context

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.Checked 2026-10-21

Indexed primary study abstract and full research article

Checked 2026-10-21. Source content and service terms may change.

Open original source ↗

Read it in context

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.Checked 2026-10-21

Indexed primary study abstract

Checked 2026-10-21. Source content and service terms may change.

Open original source ↗

Read it in context

Lynkuet prescribing information: November checkChecked 2026-11-08

Official label revised August 2026; freshly accessed, with earlier records retained.

Checked 2026-11-08. Source content and service terms may change.

Open original source ↗

Read it in context

OASIS 1 registry resultsChecked 2026-11-08

Sponsor-submitted trial record; questionnaire findings do not measure customer satisfaction.

Checked 2026-11-08. Source content and service terms may change.

Open original source ↗

Read it in context

OASIS 2 registry resultsChecked 2026-11-08

Sponsor-submitted trial record; read alongside the separately dated publication record.

Checked 2026-11-08. Source content and service terms may change.

Open original source ↗

Read it in context

Cleveland Clinic menopause service: November checkChecked 2026-11-08

Official appointment information; no booking, insurance or personal eligibility tested.

Checked 2026-11-08. Source content and service terms may change.

Open original source ↗

Read it in context

Veozah prescribing information: November checkChecked 2026-11-08

Official label revised February 2026; freshly accessed, with earlier records retained.

Checked 2026-11-08. Source content and service terms may change.

Open original source ↗

Read it in context

DAYLIGHT full article: November checkChecked 2026-11-08

Full primary article accessed through Europe PMC for this update.

Checked 2026-11-08. Source content and service terms may change.

Open original source ↗

Read it in context